Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Opera... (ed on the localized and sustained cardia...)

Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units

Date:11/10/2008

ed on the localized and sustained cardiac production of insulin-like growth factor-1 (IGF-1) following a one-time intracoronary administration in an acute care setting immediately after percutaneous coronary intervention in heart attack patients. Data from the pre-clinical study is expected to be announced in early 2009 and is designed to support the clinical potential of Corgentin. The long-term safety and efficacy of IGF-1 protein-based drugs that have already been approved by the FDA for the treatment of short stature children, are based on daily treatments for periods of a year or more. This data provides significant insights into the potential safety relating to a one-time DNA-based IGF-1 Corgentin treatment.

Commentary

"The recent FDA 510(k) clearance for our RapidBlue System, which we believe is the most powerful and easiest to use endovascular-based system in the world, represented a key milestone in completing Cardium's turnaround and strategic reposition of the Company's InnerCool investment," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium. "We are continuing to develop a portfolio of uniquely positioned medical device products based on our platform technology and expertise in the growing field of temperature modulation therapy. These new product opportunities, like our new UroCool Targeted Tissue Cooling System, are being developed for specific and defined vertical markets transactioned through strategic alignments, financings and other structured deals in keeping with our ongoing strategy to monetize InnerCool."

Reinhard added, "During this difficult economic period, we believe we have established a balanced plan to move our businesses forward, with a principal focus on completion of near-term milestones including the MATRIX clinical study for Tissue Repair's Excellarate candidate for non-healing diabetic wounds, and advancement of InnerCool's portfolio of therapeutic hypothermia products, each of whi
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related biology technology :

1. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
2. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
3. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
4. Cardium Announces Follow-On Direct Investment by Institutional Investor
5. Cardium Selected for Inclusion in Russell Microcap Index
6. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
7. Cardium Launches New AWARE Clinical Study Website
8. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
9. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
10. Cardium Reports on First Quarter 2008 Highlights and Financial Results
11. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board

Post Your Comments:

(Date:6/19/2013)... June 19, 2013 Applied Rigaku Technologies, ... that details the measurement of sulfur in ultra-low sulfur ... high resolution benchtop EDXRF analyzer . The analysis detailed ... method ISO 13032. This International Standard specifies an ... determination of sulfur content in automotive gasoline. , Regulations ...

(Date:6/19/2013)... San Diego, CA (PRWEB) June 19, 2013 ... quality pipettes, Pipette.com is now stocked with Simport’s Dropette® ... , all aimed at the customer doing basic biology, ... blood work, and serology). , For over 35 years, ... and disposable plastic labware - products like the Simport ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the fourth quarter and full year ... Fourth Quarter of Fiscal 2013 Highlights ... increased by 33.3% to RMB133.0 million ($21.4 million) from ...

(Date:6/18/2013)... 18, 2013 The Regulatory Affairs ... two new offices in Asia—one in Singapore and one ... as RAPS’ Pan-Asia office , serving the Asia ... focused on audiences within China. , The announcement comes ... with five Singapore government agencies to develop and implement ...

[0] Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 [0] Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] RAPS Opens Offices in Singapore and China

... A Night of Music & Comedy to Help Push Campaign to Victory May 14, 2008 ... Highline Ballroom, Spring ... ... Policy Project (MPP.org),will host a spring soiree, a night of comedy and music to benefit ...

... 13 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products Group Corporation ... agreement establishing a joint venture company,capable of ... May 9, General Manager of Shijiazhuang Huaxing ... and his associates visited Kiwa,s,headquarters in Beijing ...

... May 13 , - Regulated Information, ... on innovative treatments for vascular disease, eye disease ... the three month period ended,31 March 2008., ... commenting on,today,s announcement, said: "ThromboGenics, clinical development programs,are ...

Cached Biology Technology:New York Benefit to Celebrate Recent Medical Marijuana Successes 2 Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 2 Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 3 ThromboGenics N.V. - Business Update 2 ThromboGenics N.V. - Business Update 3 ThromboGenics N.V. - Business Update 4 ThromboGenics N.V. - Business Update 5 ThromboGenics N.V. - Business Update 6 ThromboGenics N.V. - Business Update 7

New York Benefit to Celebrate Recent Medical Marijuana Successes Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.ThromboGenics N.V. - Business Update

(Date:6/18/2013)... not a hacker lab. At Brandeis University, sophisticated ... are helping scientists understand the complex interplay between ... the virus, outer "shell" critical for replication. ... what we are finding will help researchers alter ... post-doctoral fellow Jason Perlmutter, first author of the ...

(Date:6/18/2013)... Joshua Obar, Ph.D., Department of Immunology and Infectious ... 2013 ICAAC Young Investigator Award for his research on ... to infection. , Obar earned his B.A. in ... on to complete his Ph.D. in Microbiology and Immunology ... Ph.D. thesis research in Edward Usherwood,s laboratory at the ...

(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...

Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2 The American Society for Microbiology honors Joshua Obar 2 The secret of DNA methylation 2

[0] Computer modeling technique goes viral at Brandeis [0] The American Society for Microbiology honors Joshua Obar [0] The secret of DNA methylation

... being slowly stroked on the skin have their own specialised ... new study from the Sahlgrenska Academy, University of Gothenburg, Sweden. ... pain. The specialised nerve fibres in the skin are called ... in the brain that are important in the emergence of ...

... 13, 2009 -- Investigators at the Burnham Institute for ... differentiate human embryonic stem cells (hESCs) into neural progenitor ... conducted by Alexei Terskikh, Ph.D., and colleagues, outlines a ... that is replicable, does not produce mutations in the ...

... Here is the latest American Chemical Society (ACS) Weekly ... news from ACS, 34 peer-reviewed journals and Chemical & ... Chemical Society as the source for this information. ... ARTICLE # 1 FOR IMMEDIATE RELEASE, Solving the ...

Signals from stroking have direct route to brain Creating ideal neural cells for clinical use American Chemical Society Weekly PressPac -- April 8, 2009

... tabs • Reusable, press-to-seal gasket and ... assembled and disassembled for hybridizing and imaging ... thickness with up to a 13 mm ... slide. Minimize specimen handling, eliminate evaporation and ...

...

... A direct, simple approach to ... well surface of an EIA ... maintains its integrity and availability ... dry, room temperature conditions ...

AC input: 230 V...

Biology Products:

Modular hybridization system from Sigma-Aldrich LC-NMR-MSn system from Bruker Daltonics Reacti-Bind Maleic Anhydride Activated Polystyrene 96-Well plates from Pierce Biotechnology, Inc.Slide Moat Microscope Slide Incubator from Sigma-Aldrich